CRISPR-Infused Stem Cell Therapy Used To Treat Patient With Rare Blood Disorder IFLScience
A private biotech venture claims to have combined CRISPR, a bacteria-derived gene-editing tool, with stem cell therapy to treat a human patient, the first time ...
View full coverage on Google News (CLICK HERE TO READ AND SEE MORE)
0 comments:
Post a Comment